Damora Therapeutics, Inc.
NASDAQDamora Therapeutics walks into its May 7 earnings report carrying two distinctly uncomfortable facts: a CFO who just stepped down and a short interest that has tripled in six weeks. The headline from Monday — CFO Lori Firmani's departure effective May 1 — lands three days before a major financial print. That timing sharpens scrutiny on the numbers rather than blunting it. Short…
Snapshot as of 7 May 2026
Damora Therapeutics walks into its May 7 earnings report carrying two distinctly uncomfortable facts: a CFO who just stepped down and a short interest that has tripled in six weeks. The headline from Monday — CFO Lori…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DMRA — free to start on ORTEX.
Sign up for free →Open DMRA on ORTEX